Stroke · cancer surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Closure of macular hole · participants with idiopathic macular hole
Face‐down positioning or posturing showed no clear difference in macular hole closure (anatomical assessment) compared with no face‐down positioning or posturing after macular hole surgery (low certainty).
1 finding from 1 review
Improved visual acuity (ETDRS chart at 4 metres) · participants with idiopathic macular hole
It is very uncertain whether face‐down positioning or posturing changes improved visual acuity (ETDRS chart at 4 metres) compared with no face‐down positioning or posturing after macular hole surgery (very low certainty).
1 finding from 1 review
Quality of life on a 0 to 100 scale. Various quality of life scales. (higher score is better) · participants with idiopathic macular hole
1 finding from 1 review
Postoperative nerve compression injury (clinical assessment) · participants with idiopathic macular hole
1 finding from 1 review
Complications within 30 days postoperatively · Patients with outcomes after colorectal cancer surgery
Prehabilitation showed no clear difference in complications within 30 days postoperatively compared with no prehabilitation (low certainty).
1 finding from 1 review
Health‐related quality of life · Patients with outcomes after colorectal cancer surgery
1 finding from 1 review
Length of hospital stay · Patients with outcomes after colorectal cancer surgery
1 finding from 1 review
All‐cause mortality · Patients with outcomes after colorectal cancer surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Safety of the programme (dropout, SAE) · Patients with outcomes after colorectal cancer surgery
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Stone‐free rate · adults with renal stones
Percutaneous nephrolithotomy may leads to higher stone‐free rate Assumed MCID: 5% compared with retrograde intrarenal surgery (low certainty).
1 finding from 1 review
Major complications · adults with renal stones
Percutaneous nephrolithotomy showed no clear difference in major complications Assumed MCID: 2% compared with retrograde intrarenal surgery (moderate certainty).
1 finding from 1 review
Secondary interventions · adults with renal stones
Percutaneous nephrolithotomy may leads to lower need for secondary interventions Assumed MCID: 5% compared with retrograde intrarenal surgery (low certainty).
1 finding from 1 review
Unplanned medical visits Assumed MCID: 5% · adults with renal stones
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Duration of hospital stay MCID: 1 day absolute difference · adults with renal stones
1 finding from 1 review
Ureteral stricture or injury Assumed MCID: 2% · adults with renal stones
Percutaneous nephrolithotomy showed no clear difference in ureteral stricture or injury Assumed MCID: 2% compared with retrograde intrarenal surgery (low certainty).
1 finding from 1 review
Quality of life Assumed MCID: NA · adults with renal stones
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Risk of a thrombotic/thromboembolic event (MI, CVA, DVT, PE) · people aged 18 and over undergoing vascular surgery
It is very uncertain whether summary of findings: Fibrin sealant changes risk of a thrombotic/thromboembolic event (MI, CVA, DVT, PE) compared with usual care (very low certainty).
1 finding from 1 review
All‐cause mortality up to 30 days · people aged 18 and over undergoing vascular surgery
1 finding from 1 review
Risk of receiving any allogeneic blood product (data only available for intraoperative blood product use) · people aged 18 and over undergoing vascular surgery
It is very uncertain whether summary of findings: Tranexamic acid changes risk of receiving any allogeneic blood product (data only available… compared with placebo (very low certainty).
1 finding from 1 review